Ajaz M. Khan,MD, MBA, CPE

MD, MBA, CPE

Medical Oncologist, Chair, CTCA Department of Medical Oncology

Ajaz Khan Chicago
quotation

My desire is to provide the best possible care by focusing on developing long-term relationships with my patients and their families so they can truly understand their goals, concerns and needs. The ability to provide high-quality, patient-centered, and personalized care deeply attracted me to Cancer Treatment Centers of America.

Location
CTCA Chicago
Specialties
Medical Oncology
Education
Medical school:

St. George’s University School of Medicine, Grenada, West Indies

Residency:

Internal Medicine - Drexel University, College of Medicine, Philadelphia, PA

Fellowship:

Hematology and Medical Oncology - Newark Beth Israel Medical Center, Newark, NJ

Advanced degrees:

Master of Business Administration - George Washington University School of Business, Washington, D.C.

Certifications

Internal Medicine, Hematology and Medical Oncology – American Board of Internal Medicine

Dr. Ajaz M. Khan joined Cancer Treatment Centers of America® (CTCA), Chicago in March 2022 as a Medical Oncologist and Chair of the CTCA® Department of Medical Oncology. In his enterprise-wide role, Dr. Khan is responsible for guiding protocols, ensuring standard-of-care guidelines are consistently met and exceeded, and helping recruit high-quality physicians to CTCA. As a Medical Oncologist, Dr. Khan primarily focuses on treating patients with breast and lung cancers.

“My goal with my patients is to provide education, compassionate care and open lines of communication,” says Dr. Khan, “and to bring information and treatment options to them, communicating clearly, so they have a comprehensive understanding of the possible next steps forward.” Dr. Khan also strives to form relationships with his patients, making sure he is easily reachable, so they can get in touch when they need him.

After his mom died from cancer when he was five years old, Dr. Khan questioned why cancer had taken her from him and what could be done to improve the lives of patients and their families. This life-long interest led him to become a research assistant during his undergraduate years, and later to serve as an Associate Scientist in Research and Development at Bayer Corporation. During this time, Dr. Khan was influenced by the oncologists he worked with, furthering his interest in treating cancer and inspiring his decision to become a medical oncologist.

After earning his medical degree with honors from St. George’s University School of Medicine in Grenada, West Indies, Dr. Khan completed his residency in Internal Medicine at Drexel University School of Medicine in Philadelphia, Pennsylvania. He went on to complete a fellowship in hematology and medical oncology at Newark Beth Israel Medical Center in Newark, New Jersey, where he became Chief Fellow, ASCO Merit Award Recipient and MORE Foundation Scholar. Dr. Khan received his MBA from George Washington University School of Business in Washington, D.C., with top honors.

Before coming to CTCA, Dr. Khan amassed significant medical leadership experience, most recently as the Chief of Hematology and Medical Oncology at St. Peter’s Health Partners Medical Associates (SPHPMA) in Albany and Troy, New York. He also served on SPHPMA executive boards, chaired their Transfusion and Cancer committees and led their Breast Cancer Program Leadership committee.

Previously, at OSF St. Anthony Medical Center in Rockford, Illinois, he served as Medical Staff President and Medical Director of Oncology Services at the Patricia D. Pepe Cancer Center. Dr. Khan is excited to lead the Department of Medical Oncology at CTCA by continuing to grow its practices, connecting with communities and providing personalized patient care.

Outside of CTCA, Dr. Khan loves spending time with his son and his wife, who is a physician assistant. He enjoys swimming and biking and is a competitive runner who has completed multiple marathons and triathlons.
Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.